MACCS |
Molecular fingerprints |
Locating anti-cancer molecules |
Kadurin et al. (2017) |
CNN |
Molecular graph |
Identifying graph convolutional fingerprints |
Duvenaud et al. (2015), Coley et al. (2017) |
CNN |
Subsequent graph- based features HE-stained tissues |
To predict the disease response in lymphocytes |
Saltz et al. (2018), Corredor et al. (2019) |
CNN |
2D chemical structure image |
Biological Activity/toxicity |
Pu et al. (2017) |
RNN |
Molecular Graph |
Generating molecules with predicted biological activity |
Olivecrona et al. (2017) |
RNN |
SMILES |
To predict molecular properties |
Pu et al. (2017) |
RNN |
Molecular fingerprints and protein sequence |
Compound protein interaction |
Wang et al. (2016) |
RNN |
SMILES |
Generating novel molecules |
Olivecrona et al. (2017) |
RNAi |
501 cancer cell lines |
To identify molecular markers for predicting cancer dependencies |
Tsherniak et al. (2017) |
DNN |
Atom pair descriptor and donor-acceptor pair descriptor |
To predict molecular bioactivity |
Ma et al. (2015) |
DNN |
Molecular descriptors and protein features |
Drug target interactions |
Wang et al. (2014) |
M-DNN |
Molecular descriptor |
To predict the chemical descriptors |
Mayr et al. (2016) |
Univariate Cox regression |
Gene expression signatures |
It identifies the predicted high-risk subgroup of victims |
Zhan et al. (2006) |
Gradient boosted regression trees |
Genome-wide polygenic scores |
To identify high-risks of breast cancer, coronary artery type 2 diabetes diseases in patients. |
Khera et al. (2018) |
VAEs |
RNA sequencing dataset |
Differentiating hidden cancer subpopulations with effectively |
Sabrina et al. (2019) |
Auto Encoder |
Fingerprints |
Virtual screening |
Kadurin et al. (2017) |